Sample Page
LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE
Written by
admin
in
6. Health
Results presented at the
17th World Stroke Congress (WSC 2025)
LT3001(Odatroltide)-202 phase 2b study met primary endpoint. No symptomatic intracranial hemorrhage…
Continue Reading
←
Meta, TikTok and Snap say they oppose Australia's youth social media ban but will comply with it – Reuters
Warm Audio WA-87jr and WA87jr SE review
→
More posts
MIT’s top research stories of 2025 | MIT News
December 22, 2025
Banksy unveils new mural in London depicting stargazing children
December 22, 2025
NGOs fear Israel registration rules risk collapse of Gaza aid operations
December 22, 2025
Discovery of the most intron-rich eukaryotic genome
December 22, 2025